Scarica l'app Stockscreener
13.67
4.11%
0.54
Precedente Chiudi:
$13.13
Aprire:
$13.33
Volume 24 ore:
2.15M
Relative Volume:
0.93
Capitalizzazione di mercato:
$932.17M
Reddito:
$2.66B
Utile/perdita netta:
$-1.21B
Rapporto P/E:
-0.7671
EPS:
-17.82
Flusso di cassa netto:
$-159.40M
1 W Prestazione:
-2.98%
1M Prestazione:
+26.11%
6M Prestazione:
-51.73%
1 anno Prestazione:
-51.75%
Intervallo 1D:
$13.12
$13.73
Intervallo di 1 settimana:
$13.01
$14.99
Portata 52W:
$9.92
$35.58
Quidelortho Corp Stock (QDEL) Company Profile
Nome
Quidelortho Corp
Settore
Industria
Telefono
(858) 552-1100
Indirizzo
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
13.67 | 932.17M | 2.66B | -1.21B | -159.40M | -17.82 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-07 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-09-19 | Ripresa | UBS | Neutral |
| 2024-09-05 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2024-03-04 | Downgrade | UBS | Neutral → Sell |
| 2024-02-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-14 | Aggiornamento | UBS | Sell → Neutral |
| 2022-09-19 | Iniziato | Citigroup | Neutral |
| 2022-07-20 | Iniziato | UBS | Sell |
| 2022-06-17 | Ripresa | JP Morgan | Neutral |
| 2022-02-22 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-03-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Reiterato | Barclays | Overweight |
| 2018-01-04 | Aggiornamento | CL King | Neutral → Buy |
| 2017-09-19 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Reiterato | Canaccord Genuity | Hold |
| 2017-02-17 | Iniziato | CL King | Neutral |
| 2016-12-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Reiterato | Barclays | Overweight |
| 2016-02-09 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Reiterato | Canaccord Genuity | Buy |
| 2015-12-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Iniziato | Barclays | Overweight |
| 2013-07-31 | Reiterato | Canaccord Genuity | Buy |
| 2011-03-03 | Downgrade | Wedbush | Outperform → Neutral |
Mostra tutto
Quidelortho Corp Borsa (QDEL) Ultime notizie
QuidelOrtho Corp (QDEL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
QuidelOrtho Corp (QDEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
QuidelOrtho Corp (QDEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
QuidelOrtho Corp (QDEL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
QuidelOrtho Corp (QDEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
QuidelOrtho Corp (QDEL) Institutional Confidence - TradingKey
Reasons to retain QuidelOrtho stock in your portfolio for now - MSN
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now - Yahoo Finance
QuidelOrtho Corp (QDEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
QuidelOrtho Corp (QDEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
QuidelOrtho Corp (QDEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Is QuidelOrtho Corp (QDEL) a Bargain After 3.3% Drop? GF Value S - GuruFocus
QuidelOrtho (QDEL) shareholders approve board slate, say-on-pay and KPMG - Stock Titan
QuidelOrtho Corp Annual Shareholders Meeting Transcript - GuruFocus
QuidelOrtho and Allo Hope Foundation partner to advance prenatal care for maternal alloimmunization - Select Science
Is the options market predicting a spike in QuidelOrtho stock? - MSN
QuidelOrtho (QDEL) up 24.1% since last earnings report: Can it continue? - MSN
Is the Options Market Predicting a Spike in QuidelOrtho Stock? - TradingView
QuidelOrtho (QDEL) director receives 1,183 shares from restricted stock unit release - Stock Titan
QuidelOrtho (QDEL) director settles 973 RSUs into common stock award - Stock Titan
QuidelOrtho (NASDAQ: QDEL) director gains 2,156 shares via RSU release - Stock Titan
QuidelOrtho Corp (QDEL) director gains 1,252 shares from RSU release - Stock Titan
QuidelOrtho CorporationCommon Stock (NQ: QDEL - FinancialContent
A Look At QuidelOrtho (QDEL) Valuation After Recent Share Price Rebound And Longer Term Weakness - Yahoo Finance
Assessing QuidelOrtho (QDEL) Valuation After A Sharp One Month Share Price Rebound - simplywall.st
QuidelOrtho (QDEL) Up 24.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk - TradingView
QuidelOrtho Corporation (QDEL) Presents at 46th Annual William Blair Growth Stock ConferenceSlideshow - Seeking Alpha
QuidelOrtho Corp stock (US7476011036): partnership news and conference appearance in focus - AD HOC NEWS
QuidelOrtho (QDEL) director adds 6,829 shares via RSU vesting - Stock Titan
Director at QuidelOrtho (QDEL) gains 6,829 shares through RSU vesting - Stock Titan
QuidelOrtho (QDEL) director RSUs vest into 6,829 shares, holding 19,469 directly - Stock Titan
QuidelOrtho (QDEL) director adds 6,829 shares through RSU vesting - Stock Titan
QuidelOrtho (QDEL) director gains 6,829 shares as RSUs vest - Stock Titan
Director R. Scott Huennekens gains 6,829 QuidelOrtho (QDEL) shares via RSU vesting - Stock Titan
QuidelOrtho Corp (QDEL) director awarded 6,829 shares in equity grant - Stock Titan
QuidelOrtho (QDEL) director Ann D. Rhoads receives 6,829 shares as RSUs vest - Stock Titan
Director at QuidelOrtho (QDEL) gains 6,829 shares via RSU vesting - Stock Titan
QuidelOrtho (QDEL) director awarded 6,829 shares via RSU vesting - Stock Titan
QuidelOrtho and Allo Hope Foundation Join Forces to Advance Educ - GuruFocus
QuidelOrtho Partners with Allo Hope Foundation for Early Pregnan - GuruFocus
QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies - Barchart
McIntyre Partnerships’ Analysis on QuidelOrtho Corporation (QDEL) - Insider Monkey
QuidelOrtho Corp stock (US7476011036): shares volatile after Q1 2026 loss and outlook reset - AD HOC NEWS
QuidelOrtho (QDEL) reports Q1 loss, tops revenue estimates - MSN
QuidelOrtho Corp stock (US7476011036): director share purchase and CFO transition in focus - AD HOC NEWS
A Look at QuidelOrtho Corp (QDEL) After 6.0% Gain -- GF Value $3 - GuruFocus
Director at QuidelOrtho (QDEL) receives 1,407 shares from RSU release - Stock Titan
QuidelOrtho Q1 2026 Earnings: EPS Misses Estimates Sharply, Stock Declines 4.28%Fiscal Year Earnings - thelegaladvocate.com
QuidelOrtho Corp (QDEL) Stock Down 4.2% -- Now Undervalued? GF S - GuruFocus
How Quidelortho Corp Com (QDEL) Affects Rotational Strategy Timing - Stock Traders Daily
Quidelortho Corp Azioni (QDEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Quidelortho Corp Azioni (QDEL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Busky Joseph M. | Chief Financial Officer |
Feb 13 '26 |
Buy |
23.66 |
3,370 |
79,742 |
10,290 |
| Blaser Brian J. | President and CEO |
Feb 13 '26 |
Buy |
23.59 |
10,540 |
248,661 |
40,073 |
| RHOADS ANN D | Director |
Dec 10 '25 |
Buy |
28.27 |
750 |
21,206 |
15,021 |
| Wilkins Joseph D Jr. | Director |
Nov 26 '25 |
Buy |
27.95 |
370 |
10,343 |
11,876 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Option Exercise |
15.74 |
7,021 |
110,511 |
41,087 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Sale |
27.81 |
4,026 |
111,965 |
37,061 |
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):